Baroreflex Activation Therapy for the Treatment of HFrEF – When CRT Is Not an Option

Published: 05 July 2021

  • Views:

    Views Icon 723

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

In this webinar, cardiologists, heart failure specialists and electrophysiologists will go through this simple implantable device that electrically stimulates the carotid baroreflex to improve symptoms of HFrEF. The panel will discuss patient indication, our latest clinical data, and incorporation into clinical practice.

This webinar is supported by CVRx.

Key Learning Objectives

  • Review the role of the baroreflex as a primary regulator of cardiovascular function and have a better understanding of the mode of action.
  • Identify the patient indication for carotid baroreceptor stimulation in heart failure with reduced ejection fraction.
  • Review the long term data and experience with baroreflex activation therapy in heart failure with reduced ejection fraction.
  • Get to know the device, and the implantation procedure of BAROSTIM.
  • Exchange with experienced physicians that prescribe and use BAROSTIM in their hospitals.

Target Audience

  • Heart Failure Specialist
  • Cardiologist
  • Interventional Cardiologist
  • Rhythmologist

More from this programme

Part 1

Welcome and Introduction

1 session
Welcome and Introduction Watch now

Part 2

Introduction: BAT Mode of Action & Patient Indication for HF

1 session
Introduction: BAT Mode of Action & Patient Indication for HF Watch now

Part 3

Clinical Results (Presentation of clinical data on Heart Failure as HOPE4HF & BeAT-HF study)

1 session
Clinical Results (Presentation of clinical data on Heart Failure as HOPE4HF & BeAT-HF study) Watch now

Part 4

Device Presentation & Implant Procedure

1 session
Device Presentation & Implant Procedure Watch now

Part 5

Case Study: advanced HF, ventricular arrhythmias and BAROSTIM

1 session
Case Study: advanced HF, ventricular arrhythmias and BAROSTIM Watch now

Part 6

Summary of Baroreflex Activation Therapy for HFrEF

1 session
Summary of Baroreflex Activation Therapy for HFrEF Watch now

Faculty Biographies

Faiez Zannad

Faiez Zannad

Professor of Therapeutics and Cardiology, Head of CIC

Prof Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU).

Prof Zannad is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension. 

Prof Zannad is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.

View full profile